(Q37943405)

25 August 2017

1 reference

title

Multifaceted link between cancer and inflammation (English)

1 reference

25 August 2017

0 references

Gautam Sethi

1

1 reference

25 August 2017

Muthu K Shanmugam

2

1 reference

25 August 2017

Lalitha Ramachandran

3

1 reference

25 August 2017

Alan Prem Kumar

4

1 reference

25 August 2017

Vinay Tergaonkar

5

1 reference

25 August 2017

publication date

1 February 2012

1 reference

25 August 2017

1 reference

25 August 2017

volume

32

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

1-15

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

25 August 2017

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cancer and inflammation: promise for biologic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and cancer: how friendly is the relationship for cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cancer is a preventable disease that requires major lifestyle changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cancer and inflammation: implications for pharmacology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Signalling pathways of the TNF superfamily: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

TNF: a master switch for inflammation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

TNF-alpha in promotion and progression of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Enhancement of experimental metastasis by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Interleukin-6 and its receptor in cancer: implications for translational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Th17 cells: a new therapeutic target in inflammatory dermatoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The role of chemokines in intestinal inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation, a key event in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Modulation of CXCL14 (BRAK) expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Oncogenes and tumor suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and cancer: The oncogene-driven connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and oncogenesis: a vicious connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

A genetically defined model for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Reflecting on 25 years with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

RET tyrosine kinase signaling in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

DNA damage, a biomarker of carcinogenesis: its measurement and modulation by diet and environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Oxidative stress and oxidative damage in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Phagocytes and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Oxygen free radicals and the systemic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Targeting NRF2 signaling for cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Oxyradicals and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Role of reactive oxygen species in skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Potential of spice-derived phytochemicals for cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cancer preventive phytochemicals as speed breakers in inflammatory signaling involved in aberrant COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Lipoxygenase metabolism: roles in tumor progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The role of cyclooxygenase and lipoxygenase in cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Potential pharmacological control of the NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Nuclear factor-kappaB activation: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

NF-kappaB and cancer: mechanisms and targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Regulation and function of NF-kappaB transcription factors in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Nuclear factor-kappa B: from clone to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Transcription factor NF-kappaB: a sensor for smoke and stress signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Molecular Pathways Linking Inflammation and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

NF-kappaB and cancer-identifying targets and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The IkappaB kinase - a bridge between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

WIP1 phosphatase is a negative regulator of NF-kappaB signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

p53 and NF-kappaB crosstalk: IKKalpha tips the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

A role for IkappaB kinase 2 in bipolar spindle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: implications in lung cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: implications in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Macrophage polarization in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

p50 Nuclear Factor- B Overexpression in Tumor-Associated Macrophages Inhibits M1 Inflammatory Responses and Antitumor Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and cancer: is the link as simple as we think?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

STATs: signal transducers and activators of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

STAT proteins: novel molecular targets for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Stat3 regulates genes common to both wound healing and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

AP-1 a target for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Transcription factors control invasion: AP-1 the first among equals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Enhanced cell motility and invasion of chicken embryo fibroblasts in response to Jun over-expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The hypoxic response: huffing and HIFing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

HIF-1 in the inflammatory microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

HIF-1alpha and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Telomere-independent Rap1 is an IKK adaptor and regulates NF-kappaB-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Mitogenic signals initiated via interleukin-6 receptor complexes in cooperation with other transmembrane molecules in myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Serum interleukin-6 levels in colorectal cancer patients--a summary of published results

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Inflammation and the development of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

An overview on the expression of cyclooxygenase-2 in tumors of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Expression of COX-2 in stomach carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBSR20100136

21 January 2018

Identifiers

DOI

10.1042/BSR20100136

1 reference

25 August 2017

1 reference